Skip to main content

MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease.

Publication ,  Journal Article
Schiebler, ML; Yankaskas, BC; Tempany, C; Spritzer, CE; Rifkin, MD; Pollack, HM; Holtz, P; Zerhouni, EA
Published in: AJR Am J Roentgenol
March 1992

Patients with adenocarcinoma of the prostate confined to the gland (stage B) are candidates for a potentially curative surgical procedure (radical retropubic prostatectomy). However, patients with adenocarcinoma that penetrates the capsule or invades the seminal vesicles (stage C) are no longer considered good candidates for surgical cure of their disease. The purpose of this study was to compare the ability of four radiologists to detect stage C disease on MR images and to evaluate interobserver variability. One hundred consecutive MR studies of the prostate were reviewed independently by four radiologists to determine whether the cancer was stage C (capsule penetration or seminal vesicle invasion by tumor). A radical prostatectomy was performed in each case, and careful histologic assessment was made of the prostatic capsule and seminal vesicles for any evidence of stage C disease. The sensitivity, specificity, and accuracy (true-positive + true-negative/100 patients) in detecting stage C disease were calculated for each of the four readers. Four receiver-operating-characteristic curves were generated and compared by means of the univariate z score. Percentage agreement was calculated for five specific areas of the prostate on MR images, and observations made by the best reader were compared with the other three to help determine interreader variability. The results showed that the sensitivity and specificity of MR imaging in detecting stage C disease ranged from .24 to .61 (mean, .48) and .49 to .79 (mean, .66), respectively. The accuracy of MR imaging ranged from .47 to .61 (mean, .55). The univariate z score test showed that one of the readers significantly differed from the other three. The average percentage agreement between that reader and the other three was 70% for the five separate anatomic regions. This study shows that considerable interobserver variation exists in the interpretation of MR images for staging cancer of the prostate. The average accuracy among four radiologists in determining the presence of stage C adenocarcinoma of the prostate from MR images was only slightly above a chance guess at .55.

Duke Scholars

Published In

AJR Am J Roentgenol

DOI

ISSN

0361-803X

Publication Date

March 1992

Volume

158

Issue

3

Start / End Page

559 / 562

Location

United States

Related Subject Headings

  • Sensitivity and Specificity
  • ROC Curve
  • Prostatic Neoplasms
  • Observer Variation
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Humans
  • Adenocarcinoma
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schiebler, M. L., Yankaskas, B. C., Tempany, C., Spritzer, C. E., Rifkin, M. D., Pollack, H. M., … Zerhouni, E. A. (1992). MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease. AJR Am J Roentgenol, 158(3), 559–562. https://doi.org/10.2214/ajr.158.3.1738994
Schiebler, M. L., B. C. Yankaskas, C. Tempany, C. E. Spritzer, M. D. Rifkin, H. M. Pollack, P. Holtz, and E. A. Zerhouni. “MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease.AJR Am J Roentgenol 158, no. 3 (March 1992): 559–62. https://doi.org/10.2214/ajr.158.3.1738994.
Schiebler ML, Yankaskas BC, Tempany C, Spritzer CE, Rifkin MD, Pollack HM, et al. MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease. AJR Am J Roentgenol. 1992 Mar;158(3):559–62.
Schiebler, M. L., et al. “MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease.AJR Am J Roentgenol, vol. 158, no. 3, Mar. 1992, pp. 559–62. Pubmed, doi:10.2214/ajr.158.3.1738994.
Schiebler ML, Yankaskas BC, Tempany C, Spritzer CE, Rifkin MD, Pollack HM, Holtz P, Zerhouni EA. MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease. AJR Am J Roentgenol. 1992 Mar;158(3):559–562.

Published In

AJR Am J Roentgenol

DOI

ISSN

0361-803X

Publication Date

March 1992

Volume

158

Issue

3

Start / End Page

559 / 562

Location

United States

Related Subject Headings

  • Sensitivity and Specificity
  • ROC Curve
  • Prostatic Neoplasms
  • Observer Variation
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Humans
  • Adenocarcinoma